Drug
Fluticasone furoate clinical trials
Also written GW685698X and Veramyst.
- studies test it
- 116
- open now
- 5
- in phase 3
- 48
- first study started
- 2003
Keep track of what changes. Save the fluticasone furoate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- FF
- 8
Studies by the year they started
115 studies that test it; most in 2005 (14)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 14 |
| 2006 | 4 |
| 2007 | 10 |
| 2008 | 7 |
| 2009 | 6 |
| 2010 | 9 |
| 2011 | 12 |
| 2012 | 9 |
| 2013 | 2 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 7 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 15
- Phase 2
- 17
- Phase 3
- 48
- Phase 4
- 33
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
- Asthma
- 33
Who runs them
Industry 95 · Other 21
GlaxoSmithKline (93) · University of Chicago (5) · University of Saskatchewan (2) · Morten Hostrup, PhD (2) · Dr. Grace Parraga (1) · Thammasat University (1) · Rambam Health Care Campus (1) · Sandoz (1)
Often tested with
Tested in the same studies.
Vilanterol (40) · GSK573719 (18) · Vilanterol trifenatate (4) · Fluticasone (3) · Umeclidinium bromide (2) · Tiotropium (2) · Batefenterol (2) · Fexofenadine (2)
Studies
Open first, then newest update. How each study uses fluticasone furoate is read from its arms, and is right about nine times in ten.
Testing it · 116
- A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaRecruitingPhase 3GlaxoSmithKlineNCT05757102Written as FF/UMEC/VI
- 129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of ExacerbationRecruitingPhase 4Western University, CanadaNCT07192016Written as fluticasone furoate(FF)/umeclidinium (UMEC)/vilanterol(VI) (100/62.5/25) mcg
- U-LABA/ICS Effects on Exercise Performance, VilanterolRecruitingNot applicableMorten Hostrup, PhDNCT06066606Written as Vilanterol and Fluticasone Furoate (low dose)
- Role of Lung Function for Exercise Capacity in Well-trained IndividualsRecruitingNot applicableMorten Hostrup, PhDNCT06077019Written as Vilanterol and Fluticasone Furoate
- Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass ExposureRecruitingPhase 4National Institute of Respiratory Diseases, MexicoNCT06571942Written as Fluthicasone / Vilanterol / Umeclidinium (100/25/62.5 mcg)
- Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled AsthmaActive, not recruitingPhase 4GlaxoSmithKlineNCT06372496Written as Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate
- Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover StudyCompletedPhase 4Thammasat UniversityNCT06905483Written as Fluticasone Furoate/Umeclidinium/Vilanterol (FUV)
- To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Single Inhaler (Trelegy Ellipta) in Participants With Symptomatic COPDCompletedPhase 4GlaxoSmithKlineNCT05535972Written as FF/UMEC/VI
- Evaluation of Triple Therapy Using Magnetic Resonance Imaging in AsthmaActive, not recruitingPhase 3Dr. Grace ParragaNCT04651777Written as FF/UMEC/VI
- Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled AsthmaCompletedPhase 3GlaxoSmithKlineNCT04937387Written as FF/VI
- A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4GlaxoSmithKlineNCT04923347Written as FF/UMEC/VI
- Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a YearCompletedPhase 4GlaxoSmithKlineNCT02889809Written as Fluticasone furoate
- Medical vs Surgical Treatment in OSA Among ChildrenStatus unknownPhase 4Assaf-Harofeh Medical CenterNCT05651750Written as Fluticasone Furoate
- A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4GlaxoSmithKlineNCT03474081Written as FF/UMEC/VI
- Effect of Fluticasone Furoate/Vilanterol on EIA in AdolescentsCompletedPhase 4Rambam Health Care CampusNCT04750603Written as Fluticasone furoate (FF)/Vilanterol (VI)
- A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic RhinitisCompletedPhase 3SandozNCT01279057Written as Fluticasone furoate 27.5 mcg/actuation nasal spray (Lek Pharmaceuticals)
- Urine Concentrations of Vilanterol After Inhaled Administration of Vilanterol/Fluticasone FuroateCompletedPhase 2Bispebjerg HospitalNCT03739294Written as Fluticasone Furoate/ Vilanterol Trifenatate
- A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4GlaxoSmithKlineNCT03478696Written as FF/UMEC/VI
- A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4GlaxoSmithKlineNCT03478683Written as FF/UMEC/VI
- INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice DesignCompletedPhase 4GlaxoSmithKlineNCT03467425Written as FF/UMEC/VI
See all 116 studies that test fluticasone furoate →
Given in every arm · 6 — fluticasone furoate is usual care beside what is tested
- Role of Montelukast in the Management of Chronic Rhinosinusitis With Nasal Polyps.Status unknownPhase 1/2Assiut UniversityNCT05143502Written as Fluticasone Furoate
- Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With AsthmaCompletedPhase 2GlaxoSmithKlineNCT03012061Written as Fluticasone Furoate
- Effect of Health Promotion on Allergic Rhinitis by Infrared-C Ray IrradiationCompletedNot applicableNanhua UniversityNCT03673384Written as Fluticasone Furoate
- Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 3GlaxoSmithKlineNCT01957163Written as FF
- Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2CompletedPhase 3GlaxoSmithKlineNCT02119286Written as FF
- A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)CompletedPhase 2GlaxoSmithKlineNCT01957202Written as FF
As the comparator · 1 — what is tested is compared with fluticasone furoate
Codes
What other systems call fluticasone furoate · ClinicalTrials.gg INT005163
- MeSH (NLM) C523187fluticasone furoateOne source NLM
- UNII (FDA) JS86977WNVFLUTICASONE FUROATEConfirmed FDA, NLM, Wikidata
- RxNorm 705022Confirmed FDA, Wikidata
- Wikidata Q2166700fluticasone furoateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C77003Fluticasone FuroateOne source FDA
- DrugBank DB08906One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C523187 | fluticasone furoate | One source NLM |
| UNII (FDA) | JS86977WNV | FLUTICASONE FUROATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 705022 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2166700 | fluticasone furoate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C77003 | Fluticasone Furoate | One source FDA |
| DrugBank | DB08906 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.